SEC Comment Letter for Regen BioPharma Inc (RGBP, RGBPP) (CIK 0001589150) (RGBP) — May 2, 2017
Regen BioPharma Inc (RGBP, RGBPP) (CIK 0001589150)
Date: May 2, 2017 · CIK: 0001589150 · Accession: 0000000000-17-015340
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-191725
Letter
Mail Stop 4 546 May 2 , 2017 Via E -mail Mr. David Koos Chief Executive Officer Regen BioPharma, Inc. 4700 Spring Street, St 304 La Mesa, CA 91942
Re: Regen BioPharma, Inc. Form 10-K for the Year Ended September 30 , 201 6 Filed December 21 , 2016 File No. 333-191725
Dear Mr. Koos :
We have comple ted our review of your filings . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
/s/ Kevin W. Vaughn
Show Raw Text
Mail Stop 4 546 May 2 , 2017 Via E -mail Mr. David Koos Chief Executive Officer Regen BioPharma, Inc. 4700 Spring Street, St 304 La Mesa, CA 91942 Re: Regen BioPharma, Inc. Form 10-K for the Year Ended September 30 , 201 6 Filed December 21 , 2016 File No. 333-191725 Dear Mr. Koos : We have comple ted our review of your filings . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, /s/ Kevin W. Vaughn Kevin W. Vaughn Accounting Branch Chief Office of Healthcare and Insurance